Q&A: Whitehead's Richard Possemato on RNAi Screening in Breast Cancer

The investigators discovered an essential pathway in breast cancer using a negative-selection RNAi screen in vivo.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.